What’s New in Femtech This Week? (July 1, 2022)

A Note from the Editor

It’s been a difficult week. Many of us, who work in women’s health, knew it was eventually happening, but it is still heartbreaking that Roe v. Wade was officially overturned a week ago. The impact of the ruling is hard to grasp, hard to accept and we are grateful for all of those who have been and continue to tirelessly advocate and fight for abortion as a healthcare right.

You’ve found some of our exclusive Inner Circle Content.

This article is only available for our Inner Circle Members. To read on:

Sign in to your Inner Circle account to access this content.
If you aren’t a member yet and would like to find out more about our Inner Circle program or sign up, click here.

You’ve found some of our exclusive Inner Circle Content.

You May Also Like

Daré Bioscience Signs Agreement with Organon for Bacterial Vaginosis Therapy

Femtech Trendwatch: Reproductive Longevity, The Business of Biotech & Startup Spotlight!